Compare BSX & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | COR |
|---|---|---|
| Founded | 1979 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.8B | 59.9B |
| IPO Year | 2010 | 2001 |
| Metric | BSX | COR |
|---|---|---|
| Price | $46.84 | $321.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 14 |
| Target Price | $93.18 | ★ $390.62 |
| AVG Volume (30 Days) | ★ 18.5M | 1.3M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | ★ 55.20 | 5.71 |
| EPS | 1.51 | ★ 15.21 |
| Revenue | $9,076,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $11.85 | $8.89 |
| Revenue Next Year | $10.16 | $6.75 |
| P/E Ratio | $30.88 | ★ $21.12 |
| Revenue Growth | ★ 12.49 | 9.31 |
| 52 Week Low | $42.20 | $244.82 |
| 52 Week High | $109.50 | $377.54 |
| Indicator | BSX | COR |
|---|---|---|
| Relative Strength Index (RSI) | 44.32 | 55.61 |
| Support Level | $42.32 | $299.49 |
| Resistance Level | $50.14 | $329.28 |
| Average True Range (ATR) | 1.53 | 7.15 |
| MACD | -0.57 | -0.19 |
| Stochastic Oscillator | 8.31 | 62.58 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.